NEW YORK (GenomeWeb News) – The Oracle Health Sciences Network today announced the inclusion of Genetic Alliance into the network, creating a bridge "linking individuals in its crowd-sourced patient registry to clinical trials."

As a result of Genetic Alliance joining the network, patients who participate in the non-profit health advocacy organization's Registries for All system can participate in trials for new therapies being carried out by other members of Oracle's network.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.